Laupheim. 88471, Germany
Phone: 0049 7392 701 555
Fax: 0049 7392 701 521
Rentschler Biotechnologie GmbH, Laupheim (Germany), is an international full-service contract manufacturer with more than 30 years of experience in the development, production and approval of biopharmaceuticals in compliance with international GMP standards. In addition, Rentschler provides regulatory advice and fill and finish services. As a pioneer in the development and production of biopharmaceuticals, Rentschler was the first company in the world to gain market authorization for an interferon-containing drug. In 2006, Rentschler announced an investment program of €50 million for expansion of production systems. By mid-2008, ten independent GMP facilities up to 2,500 L for production of clinical trial and market supplies will be available.
Rentschler has signed a preferred partnership agreement with Boehringer Ingelheim for a seamless project transfer to large-scale manufacturing of up to 15,000 L.
Full services from one source for over 30 years Rentschler Biotechnologie offers all services from one source and is therefore able to react with maximal flexibility to customers’ needs and requirements for rapid and reliable project success. Short development periods, optimal time to market and the highest standards of quality and efficiency are guaranteed. GMP certified services:· Cell Line and Process Development· Production of Active Pharmaceutical Ingredients (API)· Fill and Finish· Analytics and Quality Control· Regulatory Affairs· Quality Assurance· Corporate Project Management